Gossamer Bio, Inc. (GOSS)

2.70 -0.17 (-5.92%) USD  |  NASDAQ  |  Jan 23, 16:00
2.75 +0.05 (+1.85%) After-Hours: 20:00
More

Gossamer Bio Payables and Accrued Expenses (Quarterly)

Payables and Accrued Expenses (Quarterly) Chart

View Payables and Accrued Expenses (Quarterly) for GOSS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Payables and Accrued Expenses (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Payables and Accrued Expenses (Quarterly) Range, Past 5 Years

View Payables and Accrued Expenses (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Payables and Accrued Expenses (Quarterly) Benchmarks

View Payables and Accrued Expenses (Quarterly) Benchmarks
Start Trial
Madrigal Pharmaceuticals, Inc. Upgrade
XOMA Royalty Corp. Upgrade
Rezolute, Inc. Upgrade
Axsome Therapeutics, Inc. Upgrade
Crinetics Pharmaceuticals, Inc. Upgrade